Showing results (171-180 of 212) with videos related to

Sort By:
Pageof 22
Hepatic Medicine : Evidence and Research|March 13, 2019
Ombitasvir, paritaprevir, and ritonavir with peginterferon-α2a plus ribavirin in treatment-experienced patients with chronic hepatitis C virus genotype 1 infectionDavid Bernstein, Rakesh Tripathi, Daniel E Cohen
Hepatic Medicine : Evidence and Research|May 7, 2025
Identification of Ferroptosis -Related Genes in MAFLD/MASH and HQHF ValidationSutong Liu, Lihui Zhang, Junjiao Xu, et al.
Hepatic Medicine : Evidence and Research|May 1, 2015
Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?Sujit V Janardhan, Nancy S Reau
Hepatic Medicine : Evidence and Research|August 27, 2025
MAFLD: A Comprehensive Review of the Link Between Metabolic Dysfunction and Cardiovascular RiskAlaa M Mostafa, Ziyan Pan, Ming-Lung Yu, et al.
Hepatic Medicine : Evidence and Research|July 16, 2016
Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infectionVinay Sundaram, Kris V Kowdley
Hepatic Medicine : Evidence and Research|July 24, 2015
Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costsDaniela Paola Roggeri, Alessandro Roggeri, Elisa Rossi, et al.
Hepatic Medicine : Evidence and Research|April 14, 2020
Prospective Comparison of Transient Elastography Using Two Different Devices: Performance of FibroScan and FibroTouchJoao Tiago Serra, Johannes Mueller, Haidong Teng, et al.
Hepatic Medicine : Evidence and Research|May 6, 2020
Elbasvir/Grazoprevir for HCV Infection in Russia: A Randomized TrialKonstantin Zhdanov, Vasily Isakov, Eduard Burnevich, et al.
Hepatic Medicine : Evidence and Research|May 30, 2017
Hepatitis C infection in Egypt: prevalence, impact and management strategiesAsmaa Gomaa, Naglaa Allam, Aisha Elsharkawy, et al.
Hepatic Medicine : Evidence and Research|June 29, 2018
Biomarkers for primary biliary cholangitis: current perspectivesElias Kouroumalis, Demetrius Samonakis, Argyro Voumvouraki
Pageof 22